|
|
Prepublished online as a Blood First Edition Paper on April 3, 2003; DOI 10.1182/blood-2002-05-1475.
 Previous Article | Table of Contents | Next Article 
Blood, 1 August 2003, Vol. 102, No. 3, pp. 887-895
HEMATOPOIESIS
Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro
Mei Chang,
Peggy A. Nakagawa,
Shirley A. Williams,
Michael R. Schwartz,
Karen L. Imfeld,
Jeffrey S. Buzby, and
Diane J. Nugent
From the Children's Hospital of Orange County, Orange, CA
To determine if megakaryocytes are targeted by immune thrombocytopenic purpura (ITP) autoantibodies, as are platelets, we have studied the effects of ITP plasma on in vitro megakaryocytopoiesis. Umbilical cord blood mononuclear cells were incubated in the presence of thrombopoietin and 10% plasma from either ITP patients (n = 53) or healthy donors. The yield of megakaryocytic cells, as determined by flow cytometry, was significantly reduced in the presence of ITP plasma containing antiplatelet glycoprotein Ib (GPIb) autoantibodies (P < .001) as compared with both the control and patient plasma with no detectable anti-GPIIb/IIIa or anti-GPIb autoantibodies. Platelet absorption of anti-GPIb autoantibodies in ITP plasmas resulted in double the megakaryocyte production of the same plasmas without absorption, whereas platelet absorption of control plasma had no effect on megakaryocyte yield. Furthermore, 2 human monoclonal autoantibodies isolated from ITP patients, 2E7, specific for human platelet glycoprotein IIb heavy chain, and 5E5, specific for a neoantigen on glycoprotein IIIa expressed on activated platelets, had significant inhibitory effects on in vitro megakaryocytopoiesis (P < .001). Taken together, these data indicate that autoantibodies against either platelet GPIb or platelet GPIIb/IIIa in ITP plasma not only are involved in platelet destruction, but may also contribute to the inhibition of platelet production.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
A. E. Geddis
The regulation of proplatelet production
Haematologica,
June 1, 2009;
94(6):
756 - 759.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Podolanczuk, A. H. Lazarus, A. R. Crow, E. Grossbard, and J. B. Bussel
Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk
Blood,
April 2, 2009;
113(14):
3154 - 3160.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Gernsheimer
Chronic Idiopathic Thrombocytopenic Purpura: Mechanisms of Pathogenesis
Oncologist,
January 1, 2009;
14(1):
12 - 21.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. B. Bussel, G. Cheng, M. N. Saleh, B. Psaila, L. Kovaleva, B. Meddeb, J. Kloczko, H. Hassani, B. Mayer, N. L. Stone, et al.
Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura
N. Engl. J. Med.,
November 29, 2007;
357(22):
2237 - 2247.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. M. Boruchov, S. Gururangan, M. C. Driscoll, and J. B. Bussel
Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP)
Blood,
November 15, 2007;
110(10):
3526 - 3531.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. B. Bussel, D. J. Kuter, J. N. George, R. McMillan, L. M. Aledort, G. T. Conklin, A. E. Lichtin, R. M. Lyons, J. Nieva, J. S. Wasser, et al.
AMG 531, a Thrombopoiesis-Stimulating Protein, for Chronic ITP
N. Engl. J. Med.,
October 19, 2006;
355(16):
1672 - 1681.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. L. Webster, E. Sayeh, M. Crow, P. Chen, B. Nieswandt, J. Freedman, and H. Ni
Relative efficacy of intravenous immunoglobulin G in ameliorating thrombocytopenia induced by antiplatelet GPIIbIIIa versus GPIb{alpha} antibodies
Blood,
August 1, 2006;
108(3):
943 - 946.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. J. Nugent
Immune Thrombocytopenic Purpura of Childhood
Hematology,
January 1, 2006;
2006(1):
97 - 103.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Sakakura, H. Wada, Y. Abe, J. Nishioka, H. Tomatsu, Y. Hamaguchi, S. Oguni, H. Shiku, and T. Nobori
Usefulness of Measurement of Reticulated Platelets for Diagnosis of Idiopathic Thrombocytopenic Purpura
Clinical and Applied Thrombosis/Hemostasis,
July 1, 2005;
11(3):
253 - 261.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. Kanaji, T. Kanaji, B. Jacquelin, M. Chang, D. J. Nugent, N. Komatsu, M. Moroi, K. Izuhara, and T. J. Kunicki
Thrombopoietin initiates demethylation-based transcription of GP6 during megakaryocyte differentiation
Blood,
May 15, 2005;
105(10):
3888 - 3892.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. McMillan and C. Durette
Long-term outcomes in adults with chronic ITP after splenectomy failure
Blood,
August 15, 2004;
104(4):
956 - 960.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. J. Houwerzijl, N. R. Blom, J. J. L. van der Want, M. T. Esselink, J. J. Koornstra, J. W. Smit, H. Louwes, E. Vellenga, and J. Th. M. de Wolf
Ultrastructural study shows morphologic features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura
Blood,
January 15, 2004;
103(2):
500 - 506.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. B. Cines, J. B. Bussel, R. B. McMillan, and J. L. Zehnder
Congenital and Acquired Thrombocytopenia
Hematology,
January 1, 2004;
2004(1):
390 - 406.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
